Medesis Pharma S.A.
Clinical-stage biotech developing treatments using its AONYS® drug delivery platform.
ALMDP | PA
Overview
Corporate Details
- ISIN(s):
- FR0010844464
- LEI:
- 969500C15M96P00UR648
- Country:
- France
- Address:
- AVENUE DU GOLF, 34670 BAILLARGUES
- Website:
- https://www.medesispharma.com/
- Sector:
- Manufacturing
Description
Medesis Pharma is a clinical-stage pharmaceutical biotechnology company focused on developing treatments for serious diseases using its proprietary AONYS® drug delivery platform. The AONYS® technology is a micro-emulsion designed for buccal (oral) administration, enabling the intracellular delivery of various therapeutic molecules, including metal ions, interfering RNAs, and peptides. A key feature of the platform is its ability to transport active ingredients across the blood-brain barrier, making it a promising approach for neurological disorders. The company's development pipeline addresses diseases with high unmet medical needs, including neurodegenerative conditions like Alzheimer's disease and therapies for individuals exposed to nuclear radiation.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-10-03 18:00 |
MEDESIS PHARMA RECEIVES APPROVAL FROM THE MONTPELLIER COMMERCIAL COURT TO OPEN …
|
English | 382.6 KB | ||
| 2023-10-03 18:00 |
MEDESIS PHARMA OBTIENT UN ACCORD POUR L’OUVERTURE D’UNE PROCÉDURE DE SAUVEGARDE…
|
French | 449.9 KB | ||
| 2023-08-02 18:00 |
MEDESIS PHARMA RECOGNIZED AS A 2023 PRIX GALIEN USA NOMINEE FOR BEST STARTUP
|
English | 418.4 KB | ||
| 2023-08-02 18:00 |
MEDESIS PHARMA NOMINÉE POUR LE PRIX GALIEN USA 2023 DE LA MEILLEURE STARTUP
|
French | 450.1 KB | ||
| 2023-07-13 18:00 |
MEDESIS PHARMA PRÉSENTE UN POSTER SCIENTIFIQUE À LA CONFÉRENCE INTERNATIONALE …
|
French | 502.2 KB | ||
| 2023-07-13 18:00 |
MEDESIS PHARMA PRESENTS A SCIENTIFIC POSTER AT THE INTERNATIONAL CONFERENCE OF…
|
English | 454.7 KB | ||
| 2023-07-06 18:00 |
MEDESIS PHARMA APPEALS THE DECISION OF THE MONTPELLIER COMMERCIAL COURT IN THE …
|
English | 200.1 KB | ||
| 2023-07-06 18:00 |
MEDESIS PHARMA : FAIT APPEL DU JUGEMENT DU TRIBUNAL DE COMMERCE DE MONTPELLIER …
|
French | 228.8 KB | ||
| 2023-07-04 08:00 |
MEDESIS PHARMA: NOTICE OF ALLOWANCE IN THE UNITED STATES OF THE PATENT PROTECTI…
|
English | 330.8 KB | ||
| 2023-07-04 08:00 |
MEDESIS PHARMA : ACCORD DE DÉLIVRANCE AUX ETATS-UNIS DU BREVET PROTEGEANT LE TR…
|
French | 359.6 KB | ||
| 2023-06-08 08:00 |
MEDESIS PHARMA: OUTCOME OF THE MONTPELLIER COMMERCIAL COURT RULING IN THE LEGAL…
|
English | 65.5 KB | ||
| 2023-06-08 08:00 |
MEDESIS PHARMA : RÉSULTAT DU JUGEMENT DU TRIBUNAL DE COMMERCE DE MONTPELLIER DA…
|
French | 68.6 KB | ||
| 2023-05-24 18:00 |
MEDESIS PHARMA : Assemblée Générale Mixte du 15 juin 2023
|
French | 274.9 KB | ||
| 2023-05-23 08:00 |
MEDESIS PHARMA : RAPPORT FAVORABLE DES EXPERTS DE l'IDSMB SUR L’ÉTUDE CLINIQUE …
|
French | 193.8 KB | ||
| 2023-05-23 08:00 |
MEDESIS PHARMA: FAVORABLE REPORT FROM IDSMB EXPERTS ON THE ONGOING PHASE 2 CLIN…
|
English | 160.8 KB |
Automate Your Workflow. Get a real-time feed of all Medesis Pharma S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Medesis Pharma S.A.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Medesis Pharma S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-05-16 | N/A | Other | Sell | 1,000 | 1,170.00 EUR |
| 2024-01-18 | N/A | Other | Sell | 800 | 669.60 EUR |
| 2023-07-21 | N/A | Other | Sell | 1,000 | 1,400.00 EUR |
| 2023-07-04 | N/A | Other | Sell | 5,000 | 7,100.00 EUR |
| 2023-05-23 | N/A | Other | Sell | 3,140 | 6,908.00 EUR |
Peer Companies
